Profit Or Loss [Abstract]

Mithra Pharmaceuticals S.A. - Filing #3183197

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
22,668,000 EUR
9,030,000 EUR
Other income
4,809,000 EUR
6,574,000 EUR
Profit (loss) from operating activities
87,875,000 EUR
83,678,000 EUR
Finance income
2,838,000 EUR
1,782,000 EUR
Finance costs
13,116,000 EUR
5,987,000 EUR
Profit (loss) before tax
123,769,000 EUR
110,922,000 EUR
Tax expense (income)
6,895,000 EUR
18,835,000 EUR
Profit (loss)
116,875,000 EUR
116,875,000 EUR
92,086,000 EUR
92,086,000 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
2.69
2.25
Diluted earnings per share [abstract]
Diluted earnings (loss) per share
2.69
2.25

Talk to a Data Expert

Have a question? We'll get back to you promptly.